| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.005 | 0.9 |